In June 2025, the AIDA project launched a three-part webinar series dedicated to improving understanding and prevention of gastric cancer, one of the world’s most deadly yet preventable cancers. Led by experts from leading Spanish institutions, the series brought together clinicians, researchers, patients, and the broader public for dynamic and interactive learning sessions.
AIDA was featured at the Daiichi Sankyo European Oncology Patient Advocacy Forum in Munich, where Digestive Cancers Europe (DiCE) presented how the project uses artificial intelligence to support personalised gastric cancer prevention.
AIDA was delighted to participate in UEG Week 2025 in Berlin, one of Europe’s most important events for digestive health professionals.
AIDA was recently featured by CORDIS, the official portal of the European Commission for EU-funded research results, highlighting the project’s AI-powered diagnostic assistant for Helicobacter pylori treatment and gastric cancer prevention.
AIDA proudly participated in the ESMO Gastrointestinal Cancers Congress and the Digestive Cancers Europe Masterclass, joining leading clinicians, researchers, and patient advocates to discuss the future of digestive cancer prevention.
From 20–22 March, AIDA partner LU KPMI (University of Latvia) participated in the HUG 2025 Symposium in Seoul, South Korea, one of the leading international meetings focused on Helicobacter pylori and upper gastrointestinal diseases.
AIDA researchers have published a significant scientific advance in Nature Communications: an AI-powered “Clinician” capable of recommending personalised treatment for Helicobacter pylori (H. pylori), the leading cause of gastric cancer worldwide.
On April 24th, Digestive Cancers Europe (DiCE), a partner of the AIDA consortium, organised the ENTERO Policy Event at the European Parliament. The event brought together policymakers, clinicians, researchers, and patient advocates to highlight a growing concern in Europe: the rise of early-onset digestive cancers, including colorectal and gastric cancer.
On the 24th and 25th of March, the AIDA Consortium gathered in London for the AIDA General Assembly 2025. Hosted by Imperial College London, the two-day meeting brought together leading experts and project partners to discuss the latest advancements in
On 28 November 2024, AIDA was spotlighted at the 12th Horizon Europe Framework Programme Conference in Oviedo, Spain. Representing AIDA, Ana Miralles Marco, Project Manager of AIDA, participated in this prestigious event, presenting the project’s latest advancements in gastric cancer
One of our AIDA members, Digestive Cancers Europe (DiCE), successfully organised ENTERO 2024 in Porto, Portugal. A groundbreaking conference focused on the rising challenge of early-age onset digestive cancers. ENTERO 2024 shed light on the increasing prevalence of gastric, colorectal,
On September 27, 2024, the INCLIVA Instituto de Investigación Sanitaria, the Project Coordinator of AIDA, actively participated in the European Researchers’ Night in Valencia. This annual event, celebrated across Europe, brings science closer to the public through engaging activities and
Thank you for joining us at the AIDA Webinar: Fighting against Helicobacter Pylori: Experience Based on 10 Years of the HpEuReg. Your presence and active participation made the event a resounding success.
The AIDA survey was designed to investigate citizens’ knowledge, attitudes, and behaviors regarding chronic inflammation of the gastric mucosa and to find out the best channel to inform the general population about this under-discussed health condition.
Fighting against Helicobacter pylori: Experience based on 10 years of the HpEuReg We are delighted to invite you to our webinar commemorating the Registry’s decade of success. Join us on 24 April at 5pm CET for an inspiring event. Register
The Aida Consortium recently convened its first general assembly meeting on March 4 and 5 at i3S-Porto. The gathering focused on reviewing the project’s progress and outlining future steps to advance the innovative AI diagnostic assistant for detecting lesions before
We’re thrilled to share that our first educational session within the AIDA project, „Guidelines for management of patients with precancerous conditions and lesions in the stomach,” was a huge success! We had the privilege of having Prof. Mário-Dinis Ribeiro from
The Mediterranean Night of Women Researchers was held last 29 September 2023 in Valencia, Spain! We were thrilled to participate in the event and share our mission. „GROWING HEALTHY” is dedicated to promoting healthy lifestyle habits in the community, with
In a significant step towards developing and validating a multidisciplinary AI-powered assistant that will support clinicians in gastric cancer prevention, researchers from the IIS-La Princesa in Spain and i3S in Portugal recently presented the innovative AIDA EU project at the
The Aida project was presented during the event Healthcare in the era of AI organised by the Healthcare Data Innovation Council on May 31 in Zurich. Representatives from INCLIVA, Stratejai, and Imperial College London presented overview and objectives of the
On March 31st, Tania Fleitas and Kirill Veselkov presented an overview of the AIDA project during the second day of the TOGAS kick-off meeting in Riga (Latvia).
The AIDA project was launched in January 2023 and the kick-off meeting was held on Jan 12 at INCLIVA headquarters in Valencia, Spain. This project has a four-year duration and is supported by over 7 million euros between European and
On March 4th, Tania Fleitas Kanonnikoff from INCLIVA Biomedical Research Institute and Kirill Veselkov from Imperial College London, coordinator, and partner of the AIDA project, respectively, presented the AIDA project at the event “Empowering All Healthcare” in Valencia (Spain) and
Are you interested in knowing more about the project?
Funded by the European Union under the Horizon Europe Framework Programme Grant Agreement Nº: 101095359. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Commission. Neither the European Union nor the European Health and Digital Executive Agency can be held responsible for them.
